{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:39:32Z","timestamp":1773661172254,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ijantimicag.2008.10.028","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T04:12:35Z","timestamp":1232424755000},"page":"479-482","source":"Crossref","is-referenced-by-count":24,"title":["SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)"],"prefix":"10.1016","volume":"33","author":[{"given":"Marta","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Viveiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Boeree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.10.028_bib1","unstructured":"World Health Organization. The WHO\/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 2002-2007. Anti-tuberculosis drug resistance in the world: report No. 4. Geneva, Switzerland: WHO; 2008."},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib2","unstructured":"Direc\u00e7\u00e3o Geral de Sa\u00fade. Programa Nacional de Luta contra a Tuberculose. Ponto da situa\u00e7\u00e3o epidemiol\u00f3gica e de desempenho. Programa Nacional de Controlo da Tuberculose. Sistema de Vigil\u00e2ncia (SVIG-TB). Lisbon, Portugal: DGS; 2006."},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib3","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1128\/JCM.43.9.4880-4884.2005","volume":"43","author":"Viveiros","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(06)68392-X","article-title":"WHO's new Stop TB Strategy","volume":"367","author":"Raviglione","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.47.3.917-922.2003","article-title":"Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis","volume":"47","author":"Ordway","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijantimicag.2006.10.013","article-title":"In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis","volume":"29","author":"Martins","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/187152607782110022","article-title":"Phenothiazines as anti-multi-drug resistant tubercular agents","volume":"7","author":"Amaral","year":"2007","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib8","first-page":"771","article-title":"The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis","volume":"21","author":"Martins","year":"2007","journal-title":"In Vivo"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00280-007-0488-6","article-title":"Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells","volume":"61","author":"Fusi","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib10","unstructured":"Hegyes P, Molnar J, Mucsi I, Hever A, Szabo D, Kiesig S. Substituted disiloxanes, method for the production thereof and the use thereof for reversal of multidrug resistance (MDR). PCT\/DE00\/04110; 2000."},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib11","series-title":"BACTEC 460 TB SIRE method","author":"Siddiqi","year":"1985"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib12","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","article-title":"Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media","volume":"37","author":"Pfyffer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib13","unstructured":"De Bock A, Moulard P. MGIT 960 eXtended individual Susceptibility Testing For EpiCenter V5.53 A. TB eXiST for EpiCenter V5. 53A\u2014User's Manual V1.03. Becton Dickinson; 2008."},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib14","first-page":"137","article-title":"Effect of SILA-409, a new organosilicon multidrug resistance modifier, on human pancreatic cancer xenografts","volume":"20","author":"Zalatnai","year":"2006","journal-title":"In Vivo"},{"key":"10.1016\/j.ijantimicag.2008.10.028_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100362","article-title":"Advances in the treatment of tuberculosis","volume":"82","author":"Zhang","year":"2007","journal-title":"Clin Pharmacol Ther"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908005724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908005724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T16:58:32Z","timestamp":1589475512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908005724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0924857908005724"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.10.028","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}